Sinopharm Group Co. Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHTDF research report →
About the company
Sinopharm Group Co. Ltd. , along with its affiliates, plays a significant role in the People's Republic of China's healthcare sector, primarily engaging in the wholesale and retail trade of pharmaceuticals, medical equipment, and health-related products.
- CEO
- Wanyong Lian
- IPO
- 2011
- Employees
- 108,217
- HQ
- Shanghai, CN
Price Chart
- Market Cap
- $6.65B
- P/E
- 6.33
- P/S
- 0.08
- P/B
- 0.54
- EV/EBITDA
- 4.53
- Div Yield
- 4.72%
- Gross Margin
- 7.32%
- Op Margin
- 2.74%
- Net Margin
- 1.24%
- ROE
- 8.70%
- ROIC
- 5.52%
- Revenue
- $560.33B · -4.14%
- Net Income
- $6.97B · -1.12%
- EPS
- $2.24 · -0.88%
- Op Income
- $16.24B
- FCF YoY
- 30.73%
- 52W High
- $2.70
- 52W Low
- $2.11
- 50D MA
- $2.31
- 200D MA
- $2.46
- Beta
- 0.44
- Avg Volume
- 101
Get TickerSpark's AI analysis on SHTDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SHTDF coverage
Recent articles, reports, and earnings notes.
No research on SHTDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHTDF report →Similar companies
Peers in the same neighborhood.